FDA sets Feb target review date for IBT-backed Stemline Therapeutics
Investor Type
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
You live in:
Due to data protection policies, USA residents can not access our data.
You are in:
